Asset 1

Biotech

We have one of the largest specialist biotech teams in Europe supporting global biotech companies at all stages of development, innovation, and growth. Our clients are diverse and include therapeutics companies, suppliers of research tools, companion diagnostics, and other in vitro diagnostics and bio information solutions. Our expertise extends to broader applications of biotech across environmental, industrial, and agri-biotech.

With legal expertise grounded in scientific know-how, our support incorporates company formation, spin-out accelerator programmes, venture capital fundraisings, licensing and collaborations, clinical trials, and strategic alliances in addition to accessing capital markets and deploying intellectual property rights.

Clients value our long-held industry connections and our specialist sector expertise. Our global team is embedded in this industry with experience across many technologies, including vaccines, therapeutic proteins, monoclonal antibodies, immune-oncology, and cell-based therapies, gene therapies, and tissue-engineered products.

We are chosen by renowned biotech companies for our expertise in negotiating on pivotal IP licensing deals, resolving disputes with strategic partners, dealing with data privacy issues and avoiding competition/anti-trust risks. With our support, they push innovation boundaries and exploit commercial opportunities while remaining secure within relevant regulatory regimes.

capsules
Life sciences & healthcare

Targeted treatments – Part 1: Targeted treatments: patents for particular populations

23 September 2020
Quick read

by Paul England, DPhil

Click here to find out more
petri-dish
Coronavirus

Adrian Toutoungi, Josef Fuss and Matt Caskie discuss how biotech has managed its finances during the pandemic

4 September 2020

by Adrian Toutoungi and Josef Fuss

Click here to find out more
Life sciences & healthcare

Biologics and biosimilars litigation update

7 August 2020
QUICK READ

by Matthew Royle, Ph.D.

Click here to find out more
Life sciences & healthcare

Return to work: key issues for life sciences

4 August 2020
QUICK READ

by Helen Farr and Adrian Toutoungi

Click here to find out more

Related events

There are no upcoming events